KALLYOPE
Kallyope, headquartered at the Alexandria Center® for Life Science in New York City, is a biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis. The company’s cross-disciplinary team integrates advanced technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology that leads to transformational therapeutics to improve human health. The company’s founders are Charles Zuker, Ph.D., Lasker Award winner Tom Maniatis, Ph.D., and Nobel laureate Richard Axel, M.D. For more information, visit www.kallyope.com.
KALLYOPE
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.kallyope.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
479 M USD
Technology used in webpage:
LetsEncrypt Nginx Euro Amazon Amazon Virginia Region Ubuntu Nginx 1.14
Similar Organizations
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Column Group
The Column Group investment in Series D - Kallyope
Euclidean Capital
Euclidean Capital investment in Series D - Kallyope
Bill Gates
Bill Gates investment in Series D - Kallyope
Casdin Capital
Casdin Capital investment in Series D - Kallyope
Polaris Partners
Polaris Partners investment in Series D - Kallyope
Tao Capital Partners
Tao Capital Partners investment in Series D - Kallyope
Two Sigma Ventures
Two Sigma Ventures investment in Series D - Kallyope
Hartford HealthCare Endowment
Hartford HealthCare Endowment investment in Series D - Kallyope
StepStone Group
StepStone Group investment in Series D - Kallyope
DNS Capital
DNS Capital investment in Series D - Kallyope
Official Site Inspections
http://www.kallyope.com Semrush global rank: 4.13 M Semrush visits lastest month: 2.91 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kallyope"
Kallyope - Crunchbase Company Profile & Funding
Kallyope is pioneering the science and understanding of gut and gut-brain biology to create medicines that transform human health. Based in New York City, …See details»
Kallyope | Focusing on Big Health Challenges That Matter
The Kallyope Story Inside every human body is a complex, unexplored network of metabolic, …See details»
About Us | Kallyope
Kallyope Inc. | 430 East 29th Street, 10th Floor | New York, NY 10016See details»
Kallyope Company Profile | Management and Employees List
Kallyope, headquartered at the Alexandria Center® for Life Science in New York City, is a …See details»
Kallyope - Funding, Financials, Valuation & Investors - Crunchbase
Kallyope is funded by 19 investors. Bill & Melinda Gates Foundation and The Column Group …See details»
Kallyope 2025 Company Profile: Valuation, Funding
Kallyope General Information Description. Operator of a biotechnology company intended to discover and develop effective, easy-to-use, and well-tolerated oral agents. The company integrates technologies in sequencing, bioinformatics, …See details»
Kallyope Overview | SignalHire Company Profile
To connect with Kallyope employee register on SignalHire. Organization Website. kallyope.com …See details»
Kallyope - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Kallyope . Connect to CRM . Save . Summary. Financials. People. Technology. …See details»
Kallyope, Inc. Company Profile | New York, NY - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kallyope, …See details»
Kallyope - The Org
Founded and headquartered in New York City, Kallyope is developing an industry-leading …See details»
Kallyope Announces CEO Transition as Company Advances to its …
Aug 5, 2021 Kallyope is focused on multiple areas of high unmet need including metabolism, …See details»
Kallyope - Leadership Team - The Org
The Leadership Team at Kallyope is responsible for strategic decision-making, guiding the …See details»
Kallyope Company Profile - Office Locations, Competitors ... - Craft
Kallyope has 5 employees at their 1 location and $243 m in total funding,. See insights on …See details»
Kallyope Inc. Business Operations, SWOT, PESTLE, Porters Five …
Nov 26, 2024 Figure 1: Kallyope Inc. - Head Office - Country Figure 2: Kallyope Inc. - Key …See details»
Kallyope - Overview, News & Similar companies | ZoomInfo.com
Jun 6, 2023 Who is Kallyope. Kallyope, headquartered at the Alexandria Center® for Life …See details»
Kallyope - Updates, News, Events, Signals & Triggers - Crunchbase
Kallyope uses the science of gut-brain biology to create medicines that transform human …See details»
Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, …
Jul 6, 2022 About Kallyope. Kallyope, headquartered at the Alexandria Center® for Life …See details»
Kallyope Announces CEO Transition as Company Advances to its …
Aug 5, 2021 Kallyope, headquartered at the Alexandria Center ® for Life Science in New York …See details»
Who Owns Kallyope – CANVAS, SWOT, PESTEL & BCG Matrix …
Dec 19, 2024 Kallyope, the United States, New York based startup in the Healthcare & Life …See details»
Kallyope Discreetly Drops Disappointing Data for Oral ... - BioSpace
Feb 27, 2025 Kallyope is seeking to set itself apart in the crowded and competitive obesity …See details»